SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-097083
Filing Date
2005-05-05
Accepted
2005-05-05 12:56:19
Documents
7
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005 d10q.htm 10-Q 417622
2 FIRST AMENDMENT DATED MARCH 16, 2005 dex10213.htm EX-10.213 38977
3 SECOND AMENDMENT DATED MARCH 16, 2005 dex10214.htm EX-10.214 52857
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9576
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9564
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2975
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3026
  Complete submission text file 0001193125-05-097083.txt   536019
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 05802415
SIC: 8731 Services-Commercial Physical & Biological Research